Ginkgo Bioworks Inc.
DNA | NYSE
$7.98
+$0.10 (+1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$7.86
-$0.12 (-1.55%)
Pre-market:
Sep 22, 2026, 4:52 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 167.2M | 561.57M | 944.07M | 1.32B | 1.55B | 380.8M |
Short-Term Investments | 255.42M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 15.07M | 48.7M | 77.91M | 111.79M | 115.23M | 103.12M |
Other Long-Term Assets | 47.17M | 55.34M | 58.71M | 87.41M | 43.99M | 18.9M |
Receivables | 24.03M | 22.44M | 17.9M | 84.03M | 149.9M | 21.91M |
Inventory | n/a | n/a | 46K | 4.36M | 3.36M | 9.27M |
Other Current Assets | 25.19M | 18.73M | 18.99M | 8.71M | 698K | 3.71M |
Total Current Assets | 471.84M | 602.74M | 1B | 1.45B | 1.72B | 426.54M |
Property-Plant & Equipment | 528.7M | 598.16M | 394.99M | 718.79M | 145.77M | 121.44M |
Goodwill & Intangibles | 56.92M | 72.51M | 131.98M | 171.25M | 42.95M | 5.15M |
Total Long-Term Assets | 647.86M | 774.71M | 663.59M | 1.09B | 347.95M | 248.61M |
Total Assets | 1.12B | 1.38B | 1.67B | 2.54B | 2.07B | 675.15M |
Account Payables | 10.57M | 14.17M | 9.32M | 10.45M | 8.19M | 13.89M |
Deferred Revenue | 19.98M | 30.6M | 48.5M | 47.82M | 33.24M | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 32.12M | 26.62M | 54.38M | 52.51M | 40.31M | 41.12M |
Total Current Liabilities | 95.97M | 107.27M | 163.86M | 172.96M | 134.76M | 73.22M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 22.88M | 16.58M | 24.43M | 42.06M | 190.58M | 115.36M |
Total Long-Term Liabilities | 515.14M | 554.13M | 404.33M | 630.08M | 368.85M | 131.88M |
Total Liabilities | 611.11M | 661.39M | 568.19M | 803.04M | 503.61M | 205.1M |
Total Debt | 439.89M | 467.73M | 239.31M | 442.59M | 23.03M | 17M |
Book Value | 508.59M | 716.06M | 1.1B | 1.74B | 1.57B | 470.05M |
Book Value Per Share | 9.17 | 13.80 | 22.57 | 41.34 | 46.09 | 14.75 |
Common Stock | 6K | 5K | 5K | 190K | 161K | 129K |
Retained Earnings | -6.15B | -5.84B | -5.29B | -4.4B | -2.3B | -467.88M |
Comprehensive Income | 1.85M | -1.81M | 1.48M | -2.63M | -1.72M | 0 |
Shareholders Equity | 508.59M | 716.06M | 1.1B | 1.74B | 1.51B | 461.38M |
Total Investments | 270.48M | 48.7M | 77.91M | 111.79M | 115.23M | 103.12M |
Add to Watchlist
Select watchlists to add or remove DNA